CGRP: The hope

  Sounds like 2017 will be a good year for migraines. We have the anti-CGRP treatments coming out. Something to look forward to when we have never really had much to look forward to. Actually, there are more than four companies, developing both monoclonal antibodies that target CGRP or its receptor, as well as other … Continue reading CGRP: The hope